Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoraphat Pro vs VivaSens for Dentin Hypersensitivity
NCT04527159Completed
- Start
- Jan 2019
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of Fluoraphat Pro in dentin hypersensitivity (DH) (2 arms). Primary endpoint: Likert type scale used to measure attitudes or opinions at 24 hours. Started Jan 2019; status: completed.
02
Drugs
Fluoraphat Pro
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT04527159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04527159.